Example: Heart Attack

Clinical Trials Sponsored by Michael J. Fox Foundation for Parkinson's Research

Total 98 results

    • NCT04603326
      Not yet recruiting
      FoxBioNet: ECV (Extracellular Vesicle) 004
      Conditions: Parkinson Disease
    • NCT04507139
      Recruiting
      Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
      Conditions: Parkinson Disease
    • NCT04477785
      Recruiting
      PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort
      Conditions: Parkinson Disease
    • NCT03775447
      Completed
      Fox BioNet Project: ECV-003
      Conditions: Parkinson Disease
    • NCT03170063
      Completed
      FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
      Conditions: Parkinson Disease
    • NCT03545425
      Completed
      Fox BioNet Project: LRRK2-002
      Conditions: Parkinson Disease
    • NCT02572713
      Completed
      Systemic Synuclein Sampling Study (S4)
      Conditions: Parkinson's Disease
    • NCT01803945
      Terminated
      A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
      Conditions: Parkinson's Disease
    • NCT01705327
      Completed
      Fox Investigation for New Discovery of Biomarkers
      Conditions: Parkinson's Disease
    • NCT04634331
      Recruiting
      Dual-task Augmented Reality Treatment for Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT04551040
      Not yet recruiting
      Target Engagement of Terazosin in Healthy Adults
      Conditions: Healthy
    • NCT04506073
      Recruiting
      Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD
      Conditions: Parkinson's Disease
    • NCT04493697
      Withdrawn
      Using Neuromodulation to Improve Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT04349865
      Completed
      LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers
      Conditions: Parkinson Disease
    • NCT04334317
      Recruiting
      Effect of TAK-071 on Falls in Participants With Parkinson Disease (PD)
      Conditions: Parkinson's Disease
    • NCT04300608
      Recruiting
      Measures of Mitochondria Dysfunction in PD
      Conditions: Parkinson Disease, Mitochondrial
    • NCT03963388
      Enrolling by invitation
      PERsonalized SPEeCh Therapy for actIVE Conversation
      Conditions: Parkinson Disease
    • NCT03883217
      Not yet recruiting
      Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT03872115
      Withdrawn
      Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease
      Conditions: Parkinson Disease
    • NCT03713957
      Completed
      A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment
      Conditions: Parkinson Disease
    • NCT03470324
      Unknown status
      Combined Stimulation of STN and SNr for Dysphagia in Parkinson's Disease
      Conditions: Parkinson's Disease; Dysphagia
    • NCT03409120
      Enrolling by invitation
      Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
      Conditions: Dystonia-Parkinsonism, Adult-Onset; Parkinson Disease
    • NCT02939534
      Completed
      Antigen Presentation and Lymphocyte Response in Parkinson's Disease
      Conditions: Parkinson's Disease
    • NCT02896816
      Recruiting
      EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
      Conditions: Parkinson
    • NCT02803749
      Completed
      Buspirone in Parkinson's Disease
      Conditions: Parkinson Disease; Anxiety
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations